Targets to Therapies: Target Validation Programs
Offers Targets to Therapies: Target Validation Programs, supporting Parkinson's preclinical target validation and translational biology collaborations.
About
Targets to Therapies: Target Validation Programs sits under the Michael J. Fox Foundation for Parkinson's Research and funds target validation across mitochondrial biology, alpha-synuclein aggregation, neuroinflammation, and endolysosomal pathways. It is a family of related tracks rather than a single narrow call, all aimed at building the evidence base needed to move a Parkinson's target forward.…
BiotechMedtechNeurotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.